Endogenous type-I interferon activity is not associated with depression or fatigue in systemic lupus erythematosus

被引：20

作者：

Kellner, Erinn S. ^{[1
,2
]}

Lee, Pui Y. ^{[1
,2
,3
]}

Li, Yi ^{[1
,2
]}

Switanek, Juliana ^{[1
,2
]}

Zhuang, Haoyang ^{[1
,2
]}

Segal, Mark S. ^{[1
,2
,3
]}

Sobel, Eric S. ^{[1
,2
,4
]}

Satoh, Minoru ^{[1
,2
,4
]}

Reeves, Westley H. ^{[1
,2
,4
]}

机构：

[1] Univ Florida, Div Rheumatol & Clin Immunol, Gainesville, FL 32610 USA

[2] Univ Florida, Ctr Autoimmune Dis, Gainesville, FL 32610 USA

[3] Univ Florida, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32610 USA

[4] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2010年 / 223卷 / 1-2期

关键词：

Systemic lupus erythematosus; Depression; Fatigue; Type-I interferon; INDUCIBLE GENE-EXPRESSION; CHRONIC HEPATITIS-C; DISEASE-ACTIVITY; PSYCHIATRIC MANIFESTATIONS; COGNITIVE DYSFUNCTION; IFN-ALPHA; ANTIBODIES; SLE; ACTIVATION; RECEPTORS;

D O I：

10.1016/j.jneuroim.2010.03.018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Patients with systemic lupus erythematosus (SLE) often suffer from depression and fatigue in addition to the physical manifestations of the autoimmune disease. Elevated production of type-I interferons (IFN-I) has been found in lupus patients and IFN-I can precipitate a variety of neuropsychiatric side effects. This study was conducted to evaluate the relationship between dysregulated IFN-I production and the presence of depression or fatigue in lupus patients. Through cross-sectional and longitudinal analysis we found no significant correlation between abnormal IFN-I levels (as measured by peripheral blood expression of IFN-I-stimulated genes) and neuropsychiatric manifestations. Elevation of endogenous serum IFN-I levels is unlikely to account for the depression and fatigue associated with SLE.

引用

页码：13 / 19

页数：7

共 50 条

[21] Systemic lupus erythematosus activity and depression
Thelma Skare
Vinicius D. da Silva Magalhães
Ramón E. Siqueira
Rheumatology International, 2014, 34 : 445 - 446
[22] Type I interferon in systemic lupus erythematosus and other autoimmune diseases
Banchereau, Jacques
Pascual, Virginia
IMMUNITY, 2006, 25 (03) : 383 - 392
[23] Dendritic cells and type I interferon in systemic lupus erythematosus.
Pascual, V
Blanco, P
Gill, M
Banchereau, J
Palucka, K
ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S96 - S96
[24] Systemic Lupus Erythematosus - A Disease with A Dysregulated Type I Interferon System
Hagberg, N.
Roennblom, L.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2015, 82 (03) : 199 - 207
[25] ACQUIRED TYPE-I HYPERLIPOPROTEINEMIA WITH SYSTEMIC LUPUS ERYTHEMATOSUS, DYSGLOBULINEMIA AND HEPARIN RESISTANCE
GLUECK, CJ
LEVY, RI
GLUECK, HI
GRALNICK, HR
GRETEN, H
FREDRICKSON, DS
AMERICAN JOURNAL OF MEDICINE, 1969, 47 (02): : 318 - +
[26] The Association of Type I Interferon and Disease Activity in Childhood-Onset Systemic Lupus Erythematosus (cSLE)
Lee, Erika
Barsalou, Julie
Mohan, Smriti
Levy, Deborah
Kaplan, Mariana
Silverman, Earl
JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1265 - 1265
[27] Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
Bengtsson, AA
Sturfelt, G
Truedsson, L
Blomberg, J
Alm, G
Vallin, H
Rönnblom, L
LUPUS, 2000, 9 (09) : 664 - 671
[28] Nucleic acid sensors and type I interferon production in systemic lupus erythematosus
Shrivastav, Meena
Niewold, Timothy B.
FRONTIERS IN IMMUNOLOGY, 2013, 4
[29] A new tool for detection of type I interferon activation in systemic lupus erythematosus
Kyriakos A Kirou
George D Kalliolias
Arthritis Research & Therapy, 12
[30] A new tool for detection of type I interferon activation in systemic lupus erythematosus
Kirou, Kyriakos A.
Kalliolias, George D.
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (04)

← 1 2 3 4 5 →